Výsledky vyhledávání

Proton therapy for uveal melanoma in 43 juvenile patients: long-term results

Autor: Petrovic, A., Bergin, C., Schalenbourg, A., Goitein, G., Zografos, L.

Publikováno v: Ophthalmology, vol. 121, pp. 898-904

PURPOSE: To examine the metastatic and survival rates, eye retention probability, and the visual outcomes of juvenile patients after proton beam radiotherapy (PBRT) for uveal melanoma (UM). DESIGN: Retrospective case-factor matched control study. PAR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d055e886a1391f2301df7672975f7041
https://pubmed.ncbi.nlm.nih.gov/24405742

Zobrazit plný text záznamu

Extra-Cranial Chordoma treated with Spot-Scanning Proton Radiation Therapy: possible correlation between surgical stabilization, quality of DVH's and clinical outcome

Autor: Staab, A., Rutz, H. P., Lomax, A., Timmermann, B., Schneider, R., Ares, C., Algranati, C., Goitein, G., Hug, E.

Publikováno v: PTCOG 48; Meeting of the Particle Therapy Co-Operative Group; 20090928-20091003; Heidelberg; DOC09ptcog191 /20090924/

Background: Extra-cranial chordomas require high dose radiotherapy to achieve local control (LC). Recent, univariate analysis of our patients treated with spot scanning based proton therapy (PT) yielded a significantly reduced 5-year LC rate for pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ecdc51bbf7aa221d90c9734388db12

Zobrazit plný text záznamu

Spot-Scanning Proton Radiation Therapy for Extra-Cranial Chondrosarcoma

Autor: Staab, A., Rutz, H. P., Goitein, G., Timmermann, B., Ares, C., Schneider, R., Lomax, T., Hug, E.

Publikováno v: PTCOG 48; Meeting of the Particle Therapy Co-Operative Group; 20090928-20091003; Heidelberg; DOC09ptcog193 /20090924/

Background: Extra-cranial chondrosarcoma (ECC) require high dose radiotherapy to achieve satisfactory local control (LC). Tumor proximity to critical organs at risk poses significant dose constraints. Proton Radiotherapy (PT) has been employed at the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed5f864cc14bfc4552c53d682ea8b02
http://www.egms.de/en/meetings/ptcog2009/09ptcog193.shtml

Zobrazit plný text záznamu

Proton radiation therapy of ocular melanoma at PSI – long term analysis

Autor: Goitein, G, Schalenbourg, A, Verwey, J, Bolsi, A, Ares, C, Chamot, L, Hug, E, Zografos, L

Publikováno v: PTCOG 48; Meeting of the Particle Therapy Co-Operative Group; 20090928-20091003; Heidelberg; DOC09ptcog070 /20090924/

Objective: To analyze long term treatment outcome after proton irradiation for ocular melanomas. Materials an methods: Between March 1984 and December 2008, a total of >5076 patients with ocular lesions have been irradiated with hypo-fractionated pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710708fcbf3174afae07566d54940f60

Zobrazit plný text záznamu

Spot-scanning proton radiation therapy for extra-cranial chordoma

Autor: Rutz, HP, Staab, A, Timmermann, B, Ares, C, Lomax, A, Goitein, G, Hug, E

Publikováno v: PTCOG 48; Meeting of the Particle Therapy Co-Operative Group; 20090928-20091003; Heidelberg; DOC09ptcog167 /20090924/

Background: Extra-cranial chordomas (ECC) require high dose radiotherapy to achieve local control (LC). Tumor proximity to critical Organs at risk poses significant dose constraints. Proton-Radiotherapy (PT) has been employed at the Center for Proton

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a639ee023bc1f119c8deaa83308a7f

Zobrazit plný text záznamu

OPTIS2: a new treatment facility at PSI 25 years after introducing ocular proton therapy in Europe – project challenges and comparison with OPTIS

Autor: Verwey, J, Heufelder, J, Assenmacher, F, van Goethem, MJ, Tourovsky, A, Grossmann, M, Lomax, A, Goitein, G, Jermann, M, Zografos, L, Hug, E

Publikováno v: PTCOG 48; Meeting of the Particle Therapy Co-Operative Group; 20090928-20091003; Heidelberg; DOC09ptcog217 /20090924/

Background: In 1984 PSI started the ocular proton therapy program called OPTIS. To date more than 5200 eye tumours have been treated using a 72 MeV Philips cyclotron. Cyclotron reliability and maintenance issues led to the start of the PROSCAN projec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab07d976e57c0b80dd14770f976b351

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání